Clinical Trials Logo

Clinical Trial Summary

Eighty to 90% of SCCHN (squamous cell carcinoma of head and neck) patients in Taiwan were betel quid chewers. Thirty to 40% of them experienced mucositis World Health Organization (WHO) grade 3 from cisplatin/flurouracil (FU) in neoadjuvant chemotherapy setting. This was higher than the 8-11% reported in the Western populations and was related to oral submucous fibrosis from betel quid chewing.Severer toxicities, esp. mucositis, could be anticipated in patients of betel quid chewing treated by concurrent chemoradiotherapy (CCRT) with cisplatin/FU.PG2 Injection is proved to be safe for clinical use and is effective in stimulating the recovery of hematopoiesis and immunity from chemotherapy-induced myelosuppression. It also improved the Quality of Life, especially in fatigue, among advanced cancer patients. This study will be investigated the effect of PG2 Injection in relieving the adverse events of concurrent chemoradiotherapy, such as fatigue, myelosuppression, mucositis, body weight loss, and even the compliance of radiotherapy and chemotherapy in treatment of patients with advanced pharyngeal or laryngeal SCCHN.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01720563
Study type Interventional
Source PhytoHealth Corporation
Contact
Status Terminated
Phase Phase 2
Start date December 2012
Completion date April 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05428527 - Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue
Completed NCT04563013 - Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients N/A
Recruiting NCT05613465 - Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo N/A
Recruiting NCT05448573 - A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening
Completed NCT03897556 - Effect of High-Dose Guarana And Cancer-Related Fatigue N/A
Recruiting NCT04147312 - Fufang E'Jiao Jiang Intervening Cancer-related Fatigue N/A
Active, not recruiting NCT03318224 - Fatigue Prevalence, Severity, and State of Treatment in Germany
Completed NCT01720550 - PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care Phase 4
Not yet recruiting NCT06381557 - Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules Phase 4
Completed NCT05009693 - Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer N/A
Completed NCT03049384 - Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors N/A
Withdrawn NCT03211273 - Longitudinal Investigation of Cancer-related Fatigue
Recruiting NCT02661308 - Reducing Cancer Side-effects With Systematic Light Exposure N/A
Completed NCT02740959 - Effects of PG2 on Fatigue-Related Symptom Clusters N/A
Completed NCT03314805 - PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy Phase 2
Completed NCT03553355 - Effects of Infrared Laser Moxibustion on Cancer-related Fatigue in Breast Cancer Patients N/A
Recruiting NCT05440227 - PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients Phase 2
Enrolling by invitation NCT01228773 - The Efficacy of Health Navigation® for Cancer-Related Fatigue in Cancer Survivors Phase 2
Not yet recruiting NCT04947969 - Clinical Effect of Laser Acupuncture on Improving Cancer-related Fatigue N/A
Not yet recruiting NCT00552552 - Development and Evaluation of a Cancer-Related Fatigue Patient Education Program N/A